A report on the clinical efficacy of nadolol--a new long acting beta-blocker
Hill, L.S.; Fand, R.S.
Irish Medical Journal 72(12): 522-529
1979
ISSN/ISBN: 0332-3102 PMID: 44273 Document Number: 152616
Document emailed within 1 workday
Related Documents
Greif, S.; Roth, F.; Harnoncourt, K. 1977: The treatment of angina pectoris with a fixed combination of a beta-adrenoceptor blocker and a long-acting nitrate (double-blind trial) Schweizerische Rundschau für Medizin Praxis 66(48): 1554-1559Weth, G.; Schneider, J.; Rodatz, H.; Haubitz, I. 1985: The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate Arzneimittel-Forschung 35(11): 1711-1713
Shimomura, T.; Fujii, G.; Suzuki, S.; Miyahara, K.; Matsuura, A.; Yoshida, K.; Kasamatsu, M. 2004: Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case Kyobu Geka. Japanese Journal of Thoracic Surgery 57(3): 229-232
Greenspan, A.M.; Spielman, S.R.; Horowitz, L.N.; Laddu, A.; Senior, S. 1988: The electrophysiologic properties of esmolol, a short acting beta-blocker International Journal of Clinical Pharmacology Therapy and Toxicology 26(4): 209-216
Gustafsson, B.B.; Nitenberg, T. 1986: Large-scale synthesis of flumolol, a short-acting beta-blocker Acta Pharmaceutica Suecica 23(4): 241-244
Viray, R.; Turlapaty, P.; Laddu, A. 1988: Esmolol: a short-acting titratable beta-blocker in acute myocardial ischemia International Journal of Clinical Pharmacology Therapy and Toxicology 26(3): 153-161
Striuk, R.I.; Brytkova, I.V.; Bukhonkina, I.M.; Pavlova, L.N. 2008: Clinical efficacy of antihypertensive therapy of pregnant women with arterial hypertension with long acting nifedipine and bisoprolol Kardiologiia 48(4): 29-33
Ishida, A.; Ohya, Y. 2011: The usefulness of long-acting calcium channel blocker for hypertensive patients with metabolic syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 1): 582-586
Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Imamura, S.; Chang, K-ho.; Saitoh, Y.; Sano, E.; Akune, T.; Hanaoka, K. 2004: The successful anesthetic management of a patient with pheochromocytoma using prostaglandin E1 and a novel, short-acting beta-adrenergic blocker: landiolol hydrochloride Masui. Japanese Journal of Anesthesiology 53(7): 806-809
Furberg, C.D.; Byington, R.P. 1983: What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience Circulation 67(6 Part 2): I98-101
Benzi, L.; Marchetti, P.; Carriero, P.L.; Ciccarone, A.M.; Di Cianni, G.; Giannarelli, R.; Giovannitti, M.G.; Navalesi, R. 1987: Long-term therapy with biosynthetic human insulin: importance of short-acting/intermediate-acting insulin ratio on determining efficacy of treatment Drugs under Experimental and Clinical Research 13(5): 321-325
Bichuette, H.S. 1984: Mitral valve prolapse. Evaluation of the efficacy of nadolol on the control of clinical symptoms and on the normalization of electrocardiographic tracings Arquivos Brasileiros de Cardiologia 43(6): 449-456
Löllgen, H.; Schmidt, A.; Upmeyer, H.J. 1986: Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension Medizinische Klinik 81(23): 745-750
Yokono, K. 2001: Recent trends of development of rapid-acting and long-acting human insulin analogues--its biological characteristics and clinical availability Nihon Rinsho. Japanese Journal of Clinical Medicine 59(11): 2127-2133
Forrest, W.A. 1978: Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice British Journal of Clinical Practice 32(11): 326-332
Rao, Y.V.; Reddy, K.S.; Wasir, H.S. 1991: Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate Indian Heart Journal 43(2): 97-100
Koetsawang, S.; Ji, G.; Krishna, U.; Cuadros, A.; Dhall, G.I.; Wyss, R.; Rodriquez la Puenta, J.; Andrade, A.T.; Khan, T.; Kononova, E.S. 1990: Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Contraception 41(2): 105-124
Hoffmann, H.; Hoffmann, W. 1985: Treatment of hypertension with a new beta blocker-diuretic combination under long-term control Wiener Medizinische Wochenschrift 135(5): 127-134
Tamura, G. 2001: Long-acting beta 2-stimulants Nihon Rinsho. Japanese Journal of Clinical Medicine 59(10): 1973-1978